These Evi1-transgenic mice developed a disease resembling myelodysplastic syndrome/myeloproliferative neoplasm (MDS/MPN), characterized by anemia and thrombocytopenia, accompanied by an expansion of myelopoiesis and suppressed lymphopoiesis. The gene discussed is RUNX1; the disease is myeloproliferative neoplasm.